Vaccination strategies – Page 12 – Communicable Diseases Research

Evaluation of COVID-19 vaccination strategies with a delayed second dose

지연된 2차 접종을 통한 코로나19 예방접종 전략 평가

Research Article

Published on 2021-04-212022-09-10
Journal: PLoS Biology [Category] MERS, SARS, 변종,

Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy

Article

Published on 2021-04-132022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] absence age Analysis carried Classification tree collected Comorbidities coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine cross-sectional determinant effective Efficacy Emilia-Romagna Enhancing female gender group help Hesitancy identify Infection information involved Italy likelihood multiple logistic regression Other overcome pandemic past vaccination refusal Perceived risk performed predictor public health questionnaire random refusal reported Result Risk perception Safe SARS-CoV-2 survey vaccination Vaccination strategies Vaccine hesitancy vaccine hesitancy predictors Vaccines widespread
[DOI] 10.3390/vaccines9040378 PMC 바로가기 [Article Type] Article

Age-dependence of healthcare interventions for COVID-19 in Ontario, Canada

Research Article

Published on 2021-04-122022-10-28
Journal: BMC Public Health [Category] COVID-19, MERS,

[키워드] 95% CI Administered Admissions age age distribution analysed Canada Care COVID-19 COVID-19 patient COVID-19 patients COVID-19-related death death deaths Decline distribution Epidemiology example exceeded expand fatality healthcare Healthcare system Hospitalization hospitalizations Hospitalized increase in individual individuals Infection Infectious disease intensive care unit Intervention intubations limit medical intervention outcome Patient patient age Prevalence Prevent Probability probability of survival PROTECT quantified regions Result risk SARS-CoV-2 SARS-COV-2 infection Stress survival the disease Vaccination strategies Vaccine
[DOI] 10.1186/s12889-021-10611-4 PMC 바로가기 [Article Type] Research Article

SARS-CoV-2 re-infection risk in Austria

Observational Study

Published on 2021-04-012022-10-05
Journal: European Journal of Clinical Investigation [Category] SARS, 임상,

Assessing critical gaps in COVID-19 testing capacity: the case of delayed results in Ecuador

COVID-19 테스트 용량의 심각한 격차 평가: 에콰도르에서 지연된 결과의 경우

Research Article

Published on 2021-04-012022-09-01
Journal: BMC Public Health [Category] MERS, SARS, 진단,

[키워드] Assessing association average clinical care clinically collected contribute country COVID-19 COVID-19 cases COVID-19 testing Critical database death rate death rates Decision making Decision-making diagnostic diagnostic testing Diseases Ecuador Generalized linear model Health policy highest highlight individual inequality Infectious diseases information information management Laboratory limitation management Ministry of Health mitigate National physical processed processing reported resource Result RT-PCR testing Sample subsequent supplementary material Testing Vaccination strategies Vaccination strategy WHO’
[DOI] 10.1186/s12889-021-10715-x PMC 바로가기 [Article Type] Research Article

Vaccination strategies against COVID-19 and the diffusion of anti-vaccination views

Article

Published on 2021-03-232022-10-29
Journal: Scientific Reports [Category] COVID-19, SARS,

Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study

중국 우한에서 항 SARS-CoV-2 항체의 혈청유병률 및 체액성 면역 내구성: 종단적, 인구 수준, 횡단면 연구

Observational Study

Published on 2021-03-202022-09-11
Journal: Lancet (London, England) [Category] Fulltext, SARS, 임상, 진단, 치료법,

[키워드] 95% CI Abstract Academy adjusted analyses anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody Asymptomatic asymptomatic individual Asymptomatic individuals baseline blood sample Blood samples China Chinese Cluster college Community confirmed case confirmed cases COVID-19 outbreak cross-sectional cross-sectional study decrease determine diagnosis of COVID-19 eligible participant Epicentre family members Follow-up Follow-up visit foundation health-care household Households humoral Humoral response humoral responses IgA IgA antibodies IgG IgG antibodies IgG antibody IgM IgM antibodies immune immunoglobulins immunological Immunological testing individual Kinetics mass vaccination material median Medical Science Medical Sciences natural Neutralising Antibodies neutralising antibody neutralising antibody titre neutralising antibody titres nucleocapsid protein participant population level positive Prevent previous diagnosis proportion Protein question questionnaire random Randomly remained resurgence SARS-CoV-2 SARS-CoV-2 nucleocapsid Science selected seroconverting Seroprevalence significantly study period Symptom symptomatic individuals technology tested the epidemic titre titres translation union vaccination Vaccination strategies venous venous blood were assessed with COVID-19 Wuhan
[DOI] 10.1016/S0140-6736(21)00238-5 PMC 바로가기 [Article Type] Observational Study

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection

감염 후 6~8개월 후 회복 중인 COVID-19 환자에서 SARS-CoV-2 특이적 B 및 T 세포 반응의 지속성

Article

Published on 2021-03-122022-09-11
Journal: Med (New York, N.Y.) [Category] MERS, SARS, 변종, 임상, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 adaptive Adaptive immune response adaptive immune responses addition anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG Anti-spike antibody B cell binding domain center collected convalescent convalescent COVID-19 patient coronavirus disease Coronavirus disease 2019 Coronavirus-2 Council Course COVID-19 COVID-19 patients COVID-19 research Critical disease declined development Diagnosis disease severity Donor elevated European Horizon IgG immune immune response immune responses Immunity Immunoglobulin immunoglobulin M immunological Immunological memory Infection information Italian Level Longevity longevity of immune response Medicine medium memory B Mild Ministry of Health monitoring National natural infection Neutralizing Neutralizing activity neutralizing antibody onset of symptom patients plasma Protective protective immunity provide remained Research respiratory SARS-CoV-2 serum severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 significantly lower subset supported Swedish symptom onset T cell T cell response T cell responses tested the patient union vaccination Vaccination strategies Vaccination strategy variants virus
[DOI] 10.1016/j.medj.2021.02.001 PMC 바로가기 [Article Type] Article

Prospects of COVID-19 Vaccination in Romania: Challenges and Potential Solutions

Public Health

Published on 2021-02-102022-10-31
Journal: Frontiers in Public Health [Category] COVID-19, MERS,

Footprint of the COVID-19 Pandemic in India: A Study of Immune Landscape and Other Factors Shielding Mortality

Review Article

Published on 2020-12-242022-10-28
Journal: Analytical Cellular Pathology (Amsterdam) [Category] COVID-19, Fulltext, MERS, SARS,

[키워드] affected age BCG vaccination CD4 CD8 Cell contribute COVID-19 Cytotoxic T cell Ethnic groups expressed Factor favor Footprint genetic architecture Health HLA HLA ligand human leukocyte antigen immune response gene Immunity India infected cell infected cells Infection infection rates KIR KIR-HLA landscape Mortality motif natural killer NK cell function Other outbreak overexpressed pandemic polymorphism preventive measure receptor SARS-CoV-2 shown significantly significantly lower survival T cell T cells target the SARS-CoV-2 therapeutic intervention triggering Vaccination strategies virus-infected cell
[DOI] 10.1155/2020/6692739 PMC 바로가기 [Article Type] Review Article